Taipei, Taiwan / Düsseldorf, Germany, November 14th, 2022 – iXensor Co., Ltd. (6734. TWO) iXensor, the pioneer of mobile health, today announces that a partnership has been established with Innova Medical Group. Innova Medical Group is a leading global scale-up platform for rapid screening and diagnosis, with notably more than…
iXensor has recently been covered in AFP, Yahoo Finance, and other media about the computer vision-powered PixoTest® COVID-19 Antigen Test can effectively detect Omicron (B.1.1.529) and all major SARS-CoV-2 variants. Read the full news here: https://reurl.cc/Mb1A9m
iXensor latest Eveline·Care service enables fertility consultants to access a patient’s fertility data and remotely monitor their conditions in real-time. MobiHealth News and other media have covered this telehealth fertility tool as below: “The Eveline·Care telehealth service enables fertility consultants to access patient’s ovulation test data and recorded symptoms via a…
iXensor’s recently been mentioned again by BBC StoryWorks as one of the cutting-edge medtech companies from Taiwan! Leveraging its ICT strength and rich data from its national health insurance program, Taiwan is emerging as the innovation hub of the biomedical industry. Read more: https://reurl.cc/1YaemQ
Team Bahrain Victorious announced the press release in July – Bahrain Victorious are pleased to partner with IXensor, who will provide the team with their PixoTest POCT Covid-19 Antigen Tests. Rapid antigen tests have played an essential role in the Team’s Covid preventative measures. The partnership will strengthen Bahrain Victorious’…
Business Next’s interview with iXensor CEO Dr. Carson Chen reveals how iXensor developed its fully digitalized end-to-end COVID-19 screening solution based on its proprietary PixoTech platform. In addition to infectious disease, iXensor has turned smartphones into lab-grade diagnostic devices through PixoTech to address chronic disease and women’s health challenges. Read…
iXensor has recently announced that its PixoTest® POCT COVID-19 Antigen Test has received the CE-IVD mark. MobiHealthNews and other media covered the end-to-end fully digitalised rapid screening solution features: “It comprises a palm-sized analyser, a digital health pass app, an admin app and a HIPAA-grade health management web portal. Its diagnostic solution…
Med-Tech Innovation News talks about how iXensor can bring smartphone technology to aid COVID-19 testing. Bringing the end-to-end digital COVID-19 screening solution PixoTest® POCT COVID-19 Antigen Testing, iXensor is ready to help organizations preventing outbreaks. “PixoTest provides computer analyzed COVID-19 test results, lowering the risks caused by misinterpretation of human eyes. The…
iXensor, the pioneer of mobile health, infuses its corporate DNA of digital savviness into its upcoming product launch in January 2021. The PixoTest® COVID-19 Antigen Test, together with the PixoTest® POCT Analyzer, can yield positive results objectively in as short as 5 minutes through computer-aided analysis, minimizing the chances of misinterpretation by…
iXensor attended Medica 2020 in October and presented the PixoTech technology as well as its new application of smart COVID-19 management. “Health & Care Management” from Germany reported it as “Pioneering medical technology from Taiwan.” Read the full article here: https://www.hcm-magazin.de/zukunftsweisende-medizintechnik-aus-taiwan/150/25761/408612
